Protocol H7T-MC-TABL(a) PRasugrel IN Comparison to Clopidogrel for Inhibition of PLatelet Activation and AggrEgation (PRINCIPLE) - TIMI 44.
Latest Information Update: 19 Feb 2024
Price :
$35 *
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Coronary artery disease; Coronary disorders; Coronary thrombosis
- Focus Pharmacodynamics
- Acronyms PRINCIPLE-TIMI-44
- Sponsors Eli Lilly and Company
- 28 Jun 2011 Results published in Thrombosis and Haemostasis.
- 21 Jul 2009 Actual end date (1 Jun 2007) added as reported by ClinicalTrials.gov.
- 25 Dec 2007 Results have been published